Takeda Pharmaceutical (TAK) Construction in Progress (2017 - 2019)

Takeda Pharmaceutical's Construction in Progress history runs 3 years deep, the most recent figure standing at $88.9 million for Q1 2019.

• On a quarterly basis, Construction in Progress changed N/A year-over-year to $88.9 million in Q1 2019; TTM through Mar 2019 was $88.9 million, a N/A change from a year earlier, with the FY2019 full-year figure at $88.9 million, changed N/A from the prior year.
• Construction in Progress eased to $88.9 million in Q1 2019 per TAK's latest filing, from $1.0 billion in the prior quarter.
• Across five years, Construction in Progress topped out at $2.6 billion in Q4 2017 and bottomed at $88.9 million in Q1 2019.
• The 3-year median for Construction in Progress is $1.0 billion (2018), against an average of $1.2 billion.
• Biggest YoY gain for Construction in Progress was 60.76% in 2018; the steepest drop was 60.76% in 2018.
• Year by year, Construction in Progress stood at $2.6 billion in 2017, then sank by 60.76% to $1.0 billion in 2018, then tumbled by 91.18% to $88.9 million in 2019.
• Per Business Quant, the three latest TAK Construction in Progress figures stand at $88.9 million (Q1 2019), $1.0 billion (Q4 2018), and $2.6 billion (Q4 2017).